Department of Nephrology, Hannover Medical School, Hannover D-30625, Germany.
Cardiovasc Res. 2011 Apr 1;90(1):113-21. doi: 10.1093/cvr/cvq362. Epub 2010 Nov 18.
Multipotent mesenchymal stem cells (MSCs) have regenerative properties and are recognized as putative players in the pathogenesis of cardiovascular diseases. The underlying molecular mechanisms remain, however, sparsely explored. Our study was designed to elucidate a probable role for the multifunctional urokinase (uPA)/urokinase receptor (uPAR) system in MSC regulation. Though uPAR has been implicated in a broad spectrum of pathophysiological processes, nothing is known about uPAR in MSCs.
uPAR was required to mobilize MSCs from the bone marrow (BM) of mice stimulated with granulocyte colony-stimulating factor (G-CSF) in vivo. An insignificant amount of MSCs was mobilized in uPAR(-/-) C57BL/6J mice, whereas in wild-type animals G-CSF induced an eight-fold increase of mobilized MSCs. uPAR(-/-) mice revealed up-regulated expression of G-CSF and stromal cell-derived factor 1 (CXCR4) receptors in BM. uPAR down-regulation leads to inhibition of human MSC migration, as shown in different migration assays. uPAR down- or up-regulation resulted in inhibition or stimulation of MSC differentiation into vascular smooth muscle cells (VSMCs) correspondingly, as monitored by changes in cell morphology and expression of specific marker proteins. Injection of fluorescently labelled MSCs in non-obese diabetic/severe combined immunodeficiency (NOD/SCID) mice after femoral artery wire injury demonstrated impaired engraftment of uPAR-deficient MSCs at the place of injury.
These data suggest a multifaceted function of uPAR in MSC biology contributing to vascular repair. uPAR might guide and control the trafficking of MSCs to the vascular wall in response to injury or ischaemia and their differentiation towards functional VSMCs at the site of arterial injury.
多能间充质干细胞(MSCs)具有再生特性,被认为是心血管疾病发病机制中的潜在参与者。然而,其潜在的分子机制仍知之甚少。我们的研究旨在阐明多功能尿激酶(uPA)/尿激酶受体(uPAR)系统在 MSC 调节中的可能作用。虽然 uPAR 已被牵连到广泛的病理生理过程中,但在 MSCs 中尚未了解 uPAR。
体内用粒细胞集落刺激因子(G-CSF)刺激小鼠的骨髓(BM)时,uPAR 被需要来动员 MSCs。在 uPAR(-/-)C57BL/6J 小鼠中动员的 MSCs 数量很少,而在野生型动物中,G-CSF 诱导动员的 MSCs 增加了八倍。uPAR(-/-)小鼠显示出 BM 中 G-CSF 和基质细胞衍生因子 1(CXCR4)受体的上调表达。uPAR 下调导致人 MSC 迁移抑制,如不同迁移测定所示。uPAR 下调或上调导致 MSC 相应地分化为血管平滑肌细胞(VSMCs)的抑制或刺激,如细胞形态和特定标记蛋白的表达变化所监测到的。在股动脉线损伤后,将荧光标记的 MSC 注射到非肥胖型糖尿病/严重联合免疫缺陷(NOD/SCID)小鼠中,表明在损伤部位受损的 uPAR 缺陷 MSC 的植入受损。
这些数据表明 uPAR 在 MSC 生物学中具有多方面的功能,有助于血管修复。uPAR 可能指导和控制 MSC 向血管壁的迁移,以响应损伤或缺血,以及它们在动脉损伤部位向功能性 VSMCs 的分化。